Sartorius | SRT3 - Sales Revenues

Stock Price
225.60
Daily Change
16.60 7.94%
Monthly
-3.18%
Yearly
-7.84%
Q1 Forecast
203.68

Sartorius reported EUR927.6M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025